Jonna Kuntsi
Auto-generated profile, based on publicly available information

Jonna Kuntsi

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
DDDitte Demontis
Ditte Demontis
RWRaymond K. Walters
Raymond K. Walters
JMJoanna Martin
Joanna Martin
MMManuel Mattheisen
Manuel Mattheisen
TAThomas D. Als
Thomas D. Als
BNBenjamin M. Neale
Benjamin M. Neale
Attention deficit/hyperactivity disorder (ADHD) is a highly heritable childhood behavioral disorder affecting 5% of children and 2.5% of adults. Common genetic variants contribute substantially to ADHD susceptibility, but no variants have been robustly associated with ADHD. We report a genome-wide association meta-analysis of 20,183 individuals diagnosed with ADHD and 35,191 controls that identifies variants surpassing genome-wide significance in 12 independent loci, finding important new information about the underlying biology of ADHD. Associations are enriched in evolutionarily constrained genomic regions and loss-of-function intolerant genes and around brain-expressed regulatory marks. Analyses of three replication studies: a cohort of individuals diagnosed with ADHD, a self-reported ADHD sample and a meta-analysis of quantitative measures of ADHD symptoms in the population, support these findings while highlighting study-specific differences on genetic overlap with educational attainment. Strong concordance with GWAS of quantitative population measures of ADHD symptoms supports that clinical diagnosis of ADHD is an extreme expression of continuous heritable traits.

1 September 2021 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
SFStephen V. V Faraone
Stephen V. V Faraone
TBTobias Banaschewski
Tobias Banaschewski
DCDavid Coghill
David Coghill
YZYi Zheng
Yi Zheng
JBJoseph Biederman
Joseph Biederman
YWYufeng Wang
Yufeng Wang
Misconceptions about ADHD stigmatize affected people, reduce credibility of providers, and prevent/delay treatment. To challenge misconceptions, we curated findings with strong evidence base. We reviewed studies with more than 2000 participants or meta-analyses from five or more studies or 2000 or more participants. We excluded meta-analyses that did not assess publication bias, except for meta-analyses of prevalence. For network meta-analyses we required comparison adjusted funnel plots. We excluded treatment studies with waiting-list or treatment as usual controls. From this literature, we extracted evidence-based assertions about the disorder. We generated 208 empirically supported statements about ADHD. The status of the included statements as empirically supported is approved by 80 authors from 27 countries and 6 continents. The contents of the manuscript are endorsed by 366 people who have read this document and agree with its contents. Many findings in ADHD are supported by meta-analysis. These allow for firm statements about the nature, course, outcome causes, and treatments for disorders that are useful for reducing misconceptions and stigma.

22 June 2018 in Science
Verified
Journal Article
Open access
PDF file
TCThe Brainstorm Consortium
The Brainstorm Consortium
VAVerneri Anttila
Verneri Anttila
BBBrendan Bulik-Sullivan
Brendan Bulik-Sullivan
HFHilary K. Finucane
Hilary K. Finucane
RWRaymond K. Walters
Raymond K. Walters
BNBenjamin M. Neale
Benjamin M. Neale
Brainstorming diseases: Consistent classification of neuropsychiatric diseases is problematic because it can lead to misunderstanding of etiology. The Brainstorm Consortium examined multiple genome-wide association studies drawn from more than 200,000 patients for 25 brain-associated disorders and 17 phenotypes. Broadly, it appears that psychiatric and neurologic disorders share relatively little common genetic risk. However, different and independent pathways can result in similar clinical manifestations (e.g., psychosis, which occurs in both schizophrenia and Alzheimer's disease). Schizophrenia correlated with many psychiatric disorders, whereas the immunopathological affliction Crohn's disease did not, and posttraumatic stress syndrome was also largely independent of underlying traits. Essentially, the earlier the onset of a disorder, the more inheritable it appeared to be. Science , this issue p. eaap8757

1 April 2017 in The Lancet Psychiatry
Verified
Journal Article
Closed access
MHMartine Hoogman
Martine Hoogman
JBJanita Bralten
Janita Bralten
DHDerrek P Hibar
Derrek P Hibar
MMMaarten Mennes
Maarten Mennes
MZMarcel P Zwiers
Marcel P Zwiers
BFBarbara Franke
Barbara Franke

1 October 2018 in European Neuropsychopharmacology
Verified
Journal Article
Open access
BFBarbara Franke
Barbara Franke
GMGiorgia Michelini
Giorgia Michelini
PAPhilip Asherson
Philip Asherson
TBTobias Banaschewski
Tobias Banaschewski
ABAndrea Bilbow
Andrea Bilbow
ARAndreas Reif
Andreas Reif
Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder does not remit in puberty, but persists into adulthood. Both in childhood and adulthood, ADHD is characterised by substantial comorbidity including substance use, depression, anxiety, and accidents. However, course and symptoms of the disorder and the comorbidities may fluctuate and change over time, and even age of onset in childhood has recently been questioned. Available evidence to date is poor and largely inconsistent with regard to the predictors of persistence versus remittance. Likewise, the development of comorbid disorders cannot be foreseen early on, hampering preventive measures. These facts call for a lifespan perspective on ADHD from childhood to old age. In this selective review, we summarise current knowledge of the long-term course of ADHD, with an emphasis on clinical symptom and cognitive trajectories, treatment effects over the lifespan, and the development of comorbidities. Also, we summarise current knowledge and important unresolved issues on biological factors underlying different ADHD trajectories. We conclude that a severe lack of knowledge on lifespan aspects in ADHD still exists for nearly every aspect reviewed. We encourage large-scale research efforts to overcome those knowledge gaps through appropriately granular longitudinal studies.

1 July 2019 in American Journal of Psychiatry
Verified
Journal Article
Closed access
MHMartine Hoogman
Martine Hoogman
RMRyan Muetzel
Ryan Muetzel
JGJoao P. Guimaraes
Joao P. Guimaraes
ESElena Shumskaya
Elena Shumskaya
MMMaarten Mennes
Maarten Mennes
BFBarbara Franke
Barbara Franke